Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Sofinnova Investments
company
About
Sofinnova Investments specializes in seed, startup, mid, early stage, series A, first venture round, and corporate spinouts.
- 11 - 50
Highlights
Details
- Industries
- Biotechnology,Financial Services,Venture Capital
- Founded date
- Jan 1, 1974
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- Venture Capital
Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build successful teams, win key customers, and navigate acquisitions and IPOs. Sofinnova Ventures invests in Life Science and Technology start-ups. Their professionals are seasoned business operators, possessing deep domain and investment expertise. They know how to help entrepreneurs build successful, global businesses.
Investments
Number of Investments
Number of Lead Investments
19
9
Sofinnova Investments has made 19 investments. Their most recent investment was on
Mar 18, 2019, when Karuna Therapeutics raised $68M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Mar 18, 2019
Karuna Therapeutics
|
Series B | $68M | Biotechnology | — |
|
Nov 27, 2017
Medeor Therapeutics
|
Series B | $57M | Biotechnology | — |
|
May 9, 2017
AFYX Therapeutics
|
Series A | €16.20M | Biotechnology | Yes |
|
Apr 30, 2015
Mirna Therapeutics
|
Series D | $41.80M | Biotechnology | — |
|
Apr 6, 2015
Natera
|
Series F | $55.50M | Biotechnology | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
